carbazilquinone has been researched along with Thrombopenia in 1 studies
Carbazilquinone: An alkylating agent structurally similar to MITOMYCIN and found to be effective in the treatment of leukemia and various other neoplasms in mice. It causes leukemia and thrombocytopenia in almost all human patients.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Niikura, H | 1 |
| Hagiwara, S | 1 |
| Nishiyama, H | 1 |
| Mori, H | 1 |
| Mohri, H | 1 |
| Matsuno, K | 1 |
| Terada, H | 1 |
1 other study available for carbazilquinone and Thrombopenia
| Article | Year |
|---|---|
[Therapy of polycythemia vera and essential thrombocythemia with carboquone (author's transl)].
Topics: Adult; Aged; Azirines; Carbazilquinone; Female; Humans; Male; Middle Aged; Polycythemia Vera; Thromb | 1981 |